Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Voermans

Showing results (321-330 of 344) with videos related to

Pageof 35
Sort By:
Annals of Neurology|April 14, 2016
Mutation-specific effects on thin filament length in thin filament myopathyJosine M de Winter, Barbara Joureau, Eun-Jeong Lee, et al.
Acta Neuropathologica|April 3, 2020
Intracellular calcium leak as a therapeutic target for RYR1-related myopathiesAlexander Kushnir, Joshua J Todd, Jessica W Witherspoon, et al.
JCI Insight|July 22, 2021
Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentationDanique Beijer, Hong Joo Kim, Lin Guo, et al.
Neurology|July 8, 2018
FSHD type 2 and Bosma arhinia microphthalmia syndrome: Two faces of the same mutationKarlien Mul, Richard J L F Lemmers, Marjolein Kriek, et al.
Brain : a Journal of Neurology|September 13, 2023
Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophyRichard J L F Lemmers, Russell Butterfield, Patrick J van der Vliet, et al.
Journal of Neuromuscular Diseases|February 6, 2026
A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH studyNicol C Voermans, Jeffrey M Statland, Lawrence J Hayward, et al.
Neuromuscular Disorders : NMD|May 1, 2013
Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysisN Dlamini, N C Voermans, S Lillis, et al.
American Journal of Medical Genetics. Part A|August 11, 2020
Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndromeSandra Donkervoort, Payam Mohassel, Lucia Laugwitz, et al.
Brain : a Journal of Neurology|February 11, 2020
Clinical, morphological and genetic characterization of Brody disease: an international study of 40 patientsJoery P Molenaar, Jamie I Verhoeven, Richard J Rodenburg, et al.
BMC Neurology|August 13, 2021
Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG studyKarlijn Bouman, Jan T Groothuis, Jonne Doorduin, et al.
Pageof 35

Showing results (321-330 of 344) with videos related to

Sort By:
Pageof 35
Annals of Neurology|April 14, 2016
Mutation-specific effects on thin filament length in thin filament myopathyJosine M de Winter, Barbara Joureau, Eun-Jeong Lee, et al.
Acta Neuropathologica|April 3, 2020
Intracellular calcium leak as a therapeutic target for RYR1-related myopathiesAlexander Kushnir, Joshua J Todd, Jessica W Witherspoon, et al.
JCI Insight|July 22, 2021
Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentationDanique Beijer, Hong Joo Kim, Lin Guo, et al.
Neurology|July 8, 2018
FSHD type 2 and Bosma arhinia microphthalmia syndrome: Two faces of the same mutationKarlien Mul, Richard J L F Lemmers, Marjolein Kriek, et al.
Brain : a Journal of Neurology|September 13, 2023
Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophyRichard J L F Lemmers, Russell Butterfield, Patrick J van der Vliet, et al.
Journal of Neuromuscular Diseases|February 6, 2026
A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH studyNicol C Voermans, Jeffrey M Statland, Lawrence J Hayward, et al.
Neuromuscular Disorders : NMD|May 1, 2013
Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysisN Dlamini, N C Voermans, S Lillis, et al.
American Journal of Medical Genetics. Part A|August 11, 2020
Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndromeSandra Donkervoort, Payam Mohassel, Lucia Laugwitz, et al.
Brain : a Journal of Neurology|February 11, 2020
Clinical, morphological and genetic characterization of Brody disease: an international study of 40 patientsJoery P Molenaar, Jamie I Verhoeven, Richard J Rodenburg, et al.
BMC Neurology|August 13, 2021
Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG studyKarlijn Bouman, Jan T Groothuis, Jonne Doorduin, et al.
Pageof 35